Abstract
Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/s2665-9913(21)00417-3
Copy DOIJournal: The Lancet Rheumatology | Publication Date: Jan 18, 2022 |
Citations: 22 | License type: NO-CC CODE |
Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease.
Join us for a 30 min session where you can share your feedback and ask us any queries you have